Basaalinsuliini

Basaalinsuliini, also known as basal insulin, is a type of insulin that is administered to manage blood sugar levels in individuals with diabetes. It is typically prescribed for people with type 1 diabetes, as well as some individuals with type 2 diabetes who require insulin therapy. Basal insulin is designed to mimic the natural release of insulin by the pancreas, providing a steady, low-level supply of insulin throughout the day. This helps to maintain stable blood sugar levels between meals and at night.

Basal insulin is usually administered using an insulin pump or a multiple daily injection (MDI) regimen. Insulin pumps deliver a continuous flow of insulin, while MDI involves injecting a single dose of basal insulin at specific times, often before breakfast and before bedtime. The choice between these methods depends on individual preferences, lifestyle, and medical considerations.

Basal insulin is available in various formulations, including rapid-acting, short-acting, and intermediate-acting types. Rapid-acting insulin, such as lispro or aspart, begins to work quickly after injection and peaks within 15-30 minutes. Short-acting insulin, like regular insulin, starts working within 30 minutes and peaks around 2-4 hours later. Intermediate-acting insulin, such as NPH or glargine, begins to work within 1-2 hours and provides a more gradual release of insulin over 6-12 hours.

Basal insulin is essential for managing diabetes, as it helps to prevent hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) by maintaining a consistent insulin supply. It is typically used in combination with other types of insulin, such as prandial (meal-time) insulin, to cover the body's insulin needs throughout the day. Regular monitoring of blood sugar levels and adjustments to insulin doses are crucial for optimal diabetes management.